Autres langues SciVision Biotech Inc.

Actions

1786

TW0001786002

Cours en clôture Taiwan S.E. Autres places de cotation 00:00:00 05/07/2024			Varia. 5j.	Varia. 1 janv.
129 ^TWD	+1,57 %		-1,53 %	+66,24 %

10/05	Le produit de Scivision Biotech Inc. "Hyajoint Plus", supplément de liquide synovial à base d'acide hyaluronique à injection unique, a obtenu une licence pour un dispositif médical	CI
09/05	SciVision Biotech Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

SciVision Biotech Inc Approves Cash Dividend, Payable on August 16, 2024	26/06
Scivision Biotech Inc.'s Product, One-Injection Typehyaluronic Acid Synovial Fluid Supplement"Hyajoint Plus"Has Obtained Medical Device License	10/05
SciVision Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
SciVision Biotech Inc.?s Products, Flexotron Solo (2.2%) and Flexotron Magnum (3%) Obtain Medical Device Licenses	10/04
Scivision Biotech Inc.'s CREATEFILL Obtains Medical Device License of Class III Medical Devices	09/04
SciVision Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
SciVision Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
SciVision Biotech Inc.(TWSE:1786) added to S&P Global BMI Index	18/09/23
SciVision Biotech Inc.'s Product, Cross-Linked Hyaluronic Acid Synovial Fluid Supplement ?Hyajoint Plus? Obtains Medical Device License	05/09/23
SciVision Biotech Inc. Announces Corporate Governance Officer Changes	10/08/23
SciVision Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
SciVision Biotech Inc. Approves Cash Dividend, Payable on August 18, 2023	28/06/23
SciVision Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23
SciVision Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	03/11/22
SciVision Biotech Inc.(TWSE:1786) dropped from S&P Global BMI Index	19/09/22
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds	15/08/22
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds For 3 Months	11/08/22
SciVision Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/08/22
SciVision Biotech : Announcement of board meeting approved the consolidated financial statements for the second quarter of 2022	03/08/22
SciVision Biotech : Announcement of the company's financial officer, accounting officer and corporate governance officer approved by Board of Directors.	29/06/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SciVision Biotech Inc.

Actions

1786

TW0001786002

Autres langues

Filtres